Summary:
- This article discusses a study published in the New England Journal of Medicine that used CRISPR gene editing to treat a rare genetic disorder called CSP1 deficiency.
- The study involved a single patient, demonstrating the potential of "n-of-1" or personalized gene therapy approaches to address ultra-rare diseases.
- The treatment successfully corrected the genetic mutation in the patient, leading to improvements in their condition and highlighting the promise of CRISPR technology for personalized medicine.